Novartis Free Cash Flow:
1.178B for March 31, 2013Novartis Historical Free Cash Flow Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 1.178B |
| Dec. 31, 2012 | 3.652B |
| Sept. 30, 2012 | 3.311B |
| June 30, 2012 | 2.271B |
| March 31, 2012 | 1.892B |
| Dec. 31, 2011 | 4.049B |
| Sept. 30, 2011 | 3.65B |
| June 30, 2011 | 2.822B |
| March 31, 2011 | 1.401B |
| Dec. 31, 2010 | 3.833B |
| Sept. 30, 2010 | 2.835B |
| June 30, 2010 | 2.308B |
| March 31, 2010 | 2.859B |
| Dec. 31, 2009 | 3.472B |
| Sept. 30, 2009 | 2.638B |
| June 30, 2009 | 1.899B |
| March 31, 2009 | 1.449B |
| Dec. 31, 2008 | 2.609B |
| Sept. 30, 2008 | 2.436B |
| June 30, 2008 | 1.071B |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Free Cash Flow
Free cash flow is the amount of cash generated by a business that is available for distribution among its security holders. Security holders include debt holders, equity holders, preferred stock holders, and convertible security holders. Specifically, free cash flow is used to pay dividends, make acquisitions, develop new products, invest in new property, plant and equipment, pay interest expenses, and reduce debt.
According to many investors, free cash flow is the best indication of a company's ability to generate cash.
Learn More
NVS Free Cash Flow Benchmarks
| Companies | |
|---|---|
| Sanofi | |
| Pfizer | 4.762B |
| GlaxoSmithKline | 1.413B |
NVS Free Cash Flow Rankings
| Overall |
99th percentile 62 of 8005 |
| Sector |
99th percentile 6 of 686 in Healthcare |
| Industry |
90th percentile 5 of 55 in Drug Manufacturers - Major |
NVS Free Cash Flow Range, Past 5 Years
| Minimum | 1.071B | Jun 2008 |
| Maximum | 4.049B | Dec 2011 |
| Average | 2.582B |
